Data from Phase 3 EMBARK trial to be presented as a plenary session during the 2023 American Urological Association Annual Meeting Res...
But a game-changer occurred in 2013, when several researchers showed that a gene-editing tool called CRISPR could alter the DNA of human cells like a v...
A balanced microbiome plays an important role in maintaining human health by promoting protective immune responses and limiting excessive inflammation. But...
Regulatory authorities such as the FDA therefore require manufacturers to monitor and demonstrate HCP clearance, and to report the amount of HCP impurities...
The human brain has a sweet tooth, burning through nearly one quarter of the body's sugar energy, or glucose, each day. Now, researchers at Gladstone Insti...
Organoids also hold advantages over animal models, which inherently possess species-dependent differences and can be logistically and ethically challenging...
Clinical trials recruited hundreds of thousands of patients, while families in lockdown waited, hoping for regulatory approval of a COVID-19 vaccine that w...
Although hybridoma technology remains one of the most common techniques for antibody production, the generation and screening of hybridomas can be time-con...
Cancer is one of the leading causes of death across Asian countries. According to a report published by Janssen Asia Pacific, in 2017, overall, there wer...
The rising prevalence of chronic diseases coupled with increasing research activities for cell-based research is found to be the major factor driving the...
Drug delivery devices help in delivering the drugs which are beneficial for the targeted population to recover faster. In addition, a rising number of ca...
According to the Global Cancer Observatory, in Saudi Arabia there are 830 new kidney cancer cases were registered in 2018, furthermore, 249 people were d...
One promising approach involves delivering antiviral compounds vaginally, using inserts, gels, films, or intravaginal rings. This method is appealing becau...
Coloplast has finalised its first pivotal clinical study on Luja, a new intermittent male catheter, designed to reduce the risk of urinary tract infections...
© 2025 Biopharma Boardroom. All Rights Reserved.
